Compare Abbott Laboratories (ABT) vs KraneShares Hang Seng TECH Index ETF (KTEC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs KraneShares Hang Seng TECH Index ETF — how do they compare? Abbott Laboratories trades at $95.54 (market cap $166.94B), while KraneShares Hang Seng TECH Index ETF trades at $12.99. The key difference: Abbott Laboratories pays a 2.63% dividend while KraneShares Hang Seng TECH Index ETF pays none, and Abbott Laboratories is trading nearer its 52-week high, KraneShares Hang Seng TECH Index ETF nearer its low. Which is the better fit depends on your goals.
| ABT | KTEC | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | Sector/Thematic |
52-Week High | $136.62 | $19.51 |
52-Week Low | $82.57 | $12.00 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
KTEC trades at $12.51, up 0.89% with bearish technical signals from moving averages while oscillators remain neutral. The stock faces resistance at $13 and support at $12. Financial ratios including P/E, P/S, and ROE are unavailable in current data, limiting fundamental assessment. No recent company news or earnings updates are available for analysis.
The technical outlook appears cautious with bearish momentum indicators, though the stock shows short-term stability near current levels. Investment opportunity depends on forthcoming financial disclosures to evaluate valuation and growth prospects. Key risks include limited public financial data availability and potential volatility given the technical bearish signals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About KraneShares Hang Seng TECH Index ETF
KTEC tracks the Hang Seng TECH Index, providing targeted exposure to the 30 largest technology companies listed on the Hong Kong Stock Exchange. It focuses on innovative, internet-based businesses across sectors like e-commerce, fintech, cloud computing, and digital technology.
Read more on KTEC →
